Brain metastases affect a significant percentage of patients with advanced extracranial
malignancies. Yet, the incidence of brain metastases remains poorly described, largely due …

Background Patients with metastatic breast cancer (MBC) are living longer, but the
development of brain metastases often limits their survival. We conducted a systematic …

A recent meeting was held on March 22, 2019, among the FDA, clinical scientists,
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …

Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is
known about brain metastases than cancer-related entities of similar incidence. Advances in …

Imaging of brain metastases (BMs) has advanced greatly over the past decade. In this
review, we discuss the main challenges that BMs pose in clinical practice and describe the …

Brain metastases are an increasing global public health concern, even as survival rates
improve for patients with metastatic disease. Both metastases and the sequelae of their …

Background There is an increasing need for developing effective therapies for managing
intracranial disease in patients with human epidermal growth factor receptor 2-positive …

Abstract Background Current National Comprehensive Cancer Network and American
Society of Clinical Oncology guidelines recommend against screening breast cancer …

Background Although intracranial metastatic disease (IMD) is a frequent complication of
cancer, most cancer registries do not capture these cases. Consequently, a data-gap exists …

Simple Summary Brain metastases (BM) from colorectal cancer (CRC) are rare. There is
little available information regarding incidence, risk factors, prognostic factors, treatment …